How big is the Global Virtual Clinical Trials Market?

The Global Virtual Clinical Trials Market size is expected to reach USD 9.52 billion in 2024 and grow at a CAGR of 9.34% to reach USD 14.88 billion by 2029. Read More

What is the current Global Virtual Clinical Trials Market size?

In 2024, the Global Virtual Clinical Trials Market size is expected to reach USD 9.52 billion. Read More

Who are the key players in Global Virtual Clinical Trials Market?

ICON PLC , Laboratory Corporation of America Holdings (Covance Inc.) , Oracle Corporation , Parexel International Corporation and IQVIA Holdings Inc. are the major companies operating in the Global Virtual Clinical Trials Market. Read More

Which is the fastest growing region in Global Virtual Clinical Trials Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Virtual Clinical Trials Market?

In 2024, the North America accounts for the largest market share in Global Virtual Clinical Trials Market. Read More

What years does this Global Virtual Clinical Trials Market cover, and what was the market size in 2023?

In 2023, the Global Virtual Clinical Trials Market size was estimated at USD 8.71 billion. The report covers the Global Virtual Clinical Trials Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Virtual Clinical Trials Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Global Virtual Clinical Trials Market Share

Statistics for the 2023 & 2024 Global Virtual Clinical Trials market share, created by Mordor Intelligence™ Industry Reports. Global Virtual Clinical Trials share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Global Virtual Clinical Trials Industry

The virtual clinical trials market is highly competitive and consists of several major players. The players operating in the market are operating on different competitive factors, such as experience in the pharmaceutical, experience in clinical trials, and investment in technology. The strategies adopted by the market participants are partnerships, collaborations, agreement, product launch, and product expansion. The players include Clinical Ink inc., IQVIA Holdings Inc., ICON PLC, Laboratory Corporation of America Holdings (Covance Inc.), LEO Innovation Lab., Dassault Systemes SE (Medidata Solutions Inc.), Oracle Corporation, Parexel International Corporation, Medable Inc., and Signant Health.